6.
Masiello F, Tirelli V, Sanchez M, van den Akker E, Gabriella G, Marconi M
. Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype. Transfusion. 2013; 54(4):1059-70.
PMC: 3942379.
DOI: 10.1111/trf.12391.
View
7.
Migliaccio A, Grazzini G, Hillyer C
. Ex vivo generated red cells as transfusion products. Stem Cells Int. 2012; 2012:615412.
PMC: 3337600.
DOI: 10.1155/2012/615412.
View
8.
Kupzig S, Parsons S, Curnow E, Anstee D, Blair A
. Superior survival of cultured human reticulocytes following transfusion into mice. Haematologica. 2016; 102(3):476-483.
PMC: 5394952.
DOI: 10.3324/haematol.2016.154443.
View
9.
van den Akker E, Satchwell T, Pellegrin S, Daniels G, Toye A
. The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica. 2010; 95(9):1594-8.
PMC: 2930963.
DOI: 10.3324/haematol.2009.019828.
View
10.
Leberbauer C, Boulme F, Unfried G, Huber J, Beug H, Mullner E
. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood. 2004; 105(1):85-94.
DOI: 10.1182/blood-2004-03-1002.
View
11.
Heshusius S, Heideveld E, Burger P, Thiel-Valkhof M, Sellink E, Varga E
. Large-scale in vitro production of red blood cells from human peripheral blood mononuclear cells. Blood Adv. 2019; 3(21):3337-3350.
PMC: 6855111.
DOI: 10.1182/bloodadvances.2019000689.
View
12.
Migliaccio G, Sanchez M, Masiello F, Tirelli V, Varricchio L, Whitsett C
. Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant. 2010; 19(4):453-69.
PMC: 4397648.
DOI: 10.3727/096368909X485049.
View
13.
Gallego-Murillo J, Iacono G, van der Wielen L, van den Akker E, von Lindern M, Wahl S
. Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors. Biotechnol Bioeng. 2022; 119(11):3096-3116.
PMC: 9804173.
DOI: 10.1002/bit.28193.
View
14.
Higgins V
. Leukocyte-reduced blood components: patient benefits and practical applications. Oncol Nurs Forum. 1996; 23(4):659-67.
View
15.
Mohandas N, Gallagher P
. Red cell membrane: past, present, and future. Blood. 2008; 112(10):3939-48.
PMC: 2582001.
DOI: 10.1182/blood-2008-07-161166.
View
16.
van den Akker E, Satchwell T, Williamson R, Toye A
. Band 3 multiprotein complexes in the red cell membrane; of mice and men. Blood Cells Mol Dis. 2010; 45(1):1-8.
DOI: 10.1016/j.bcmd.2010.02.019.
View
17.
Brewer G
. Inherited erythrocyte metabolic and membrane disorders. Med Clin North Am. 1980; 64(4):579-96.
DOI: 10.1016/s0025-7125(16)31582-6.
View
18.
An X, Mohandas N
. Disorders of red cell membrane. Br J Haematol. 2008; 141(3):367-75.
DOI: 10.1111/j.1365-2141.2008.07091.x.
View
19.
Pollet H, Conrard L, Cloos A, Tyteca D
. Plasma Membrane Lipid Domains as Platforms for Vesicle Biogenesis and Shedding?. Biomolecules. 2018; 8(3).
PMC: 6164003.
DOI: 10.3390/biom8030094.
View
20.
Subczynski W, Pasenkiewicz-Gierula M, Widomska J, Mainali L, Raguz M
. High Cholesterol/Low Cholesterol: Effects in Biological Membranes: A Review. Cell Biochem Biophys. 2017; 75(3-4):369-385.
PMC: 5645210.
DOI: 10.1007/s12013-017-0792-7.
View